TGFB1 and pulmonary fibrosis: It has been previously demonstrated that TLR4 signaling in SSc patients induces the production of transforming growth factor β (TGFβ), which triggers fibroblast proliferation, with consequent development of skin and pulmonary fibrosis [9].